s

Portfolio/News

EMIT Corporation is focused on the design, development, manufacture, and sale of devices and related products for the treatment and prevention of hypothermia caused by traumatic, environmental, and procedure related occurrences.  The technology was exclusively licensed from The University of Texas Health Science Center at Houston and The University of Texas at Austin following nearly $4.0 million of research and development funding provided by the United States Army Telemedicine and Advanced Technology Research Center. EMIT Corporation raised an additional $3.3 million from CitareTx Investment Partners I, LP in a Series A Preferred Stock financing.

News:
 

 

Houston Medical Robotics, Inc. is developing & commercializing revolutionary image guided hand-held medical robotics for use in various therapeutic applications. Our devices provide safer, cheaper, and more effective procedural alternatives, thereby increasing caregiver efficiency, hospital/clinic revenue, and overall patient satisfaction. Houston Medical Robotics, Inc. raised $2.2 million from CitareTx Investment Partners I, LP in a Series A Preferred Stock financing.

News:

 

Coauglex, Inc. is focused on the development, manufacture, and sale of a MEMS based point of injury coagulation assessment tool. The device will provide actionable results within 120 seconds without the need for pre-calibration and with limited blood sampling (50 microliters).